ITIF：2024年利用人工智能加速生物制药行业创新报告（英文版）

Drug development is a costly, lengthy, and risky process, marked by declining productivity. Bringing a new drug to market can cost billions of dollars and take over a decade, with fewer than 8 percent of early candidates succeeding. • AI has the potential to boost the efficiency of drug development, accelerating the delivery of new therapies and fostering competition, which could improve public health outcomes. • AI applications span the entire drug development pipeline—from speeding up drug